HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Support For Culturelle Probiotic Claims Doesn't Settle Well In NAD Review

This article was originally published in The Rose Sheet

Executive Summary

Council of Better Business Bureau's investigative arm "had several significant concerns" with research i-Health submitted to support express claims including “Exclusively with the #1 Proven Effective Probiotic” and implied claims including that its GG probiotic strain is the most effective probiotic in terms of overall health-related benefits. NAD attorneys concluded i-Health’s evidence "was not a good fit for the messages reasonably conveyed by the challenged claims."

You may also be interested in...



Culturelle 'IBS Complete Support' Brand Name Among Ad Claims Not Supported In P&G Challenge

NAD attorneys didn’t act on P&G challenge to i-Health labeling Culturelle IBS Complete Support as medical food. They agreed with P&G’s challenge against claims Royal DSM subsidiary used on packaging and online, including “Living with IBS is difficult, taking Culturelle IBS complete support to help manage symptoms is easy.”

Health, Beauty And Wellness News: Coppertone, Nature Made, Culturelle, Renew Life, USANA

Culturelle Healthy Balance probiotic launches; Renew Life enters digestive health market; USANA Q1 sales up on Asia-Pacific business; Coppertone sponsors 4-H 'Sun Smarts Challenge'; Nature Made 'Healthy Together' offers wellness solutions; FTC stings marketer spray marketer; and kratom salmonella recalls spread.

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel